245 related articles for article (PubMed ID: 20805487)
1. The serine/arginine-rich protein SF2/ASF regulates protein sumoylation.
Pelisch F; Gerez J; Druker J; Schor IE; Muñoz MJ; Risso G; Petrillo E; Westman BJ; Lamond AI; Arzt E; Srebrow A
Proc Natl Acad Sci U S A; 2010 Sep; 107(37):16119-24. PubMed ID: 20805487
[TBL] [Abstract][Full Text] [Related]
2. Identification of a non-covalent ternary complex formed by PIAS1, SUMO1, and UBC9 proteins involved in transcriptional regulation.
Mascle XH; Lussier-Price M; Cappadocia L; Estephan P; Raiola L; Omichinski JG; Aubry M
J Biol Chem; 2013 Dec; 288(51):36312-27. PubMed ID: 24174529
[TBL] [Abstract][Full Text] [Related]
3. Association of Ubc9, an E2 ligase for SUMO conjugation, with p53 is regulated by phosphorylation of p53.
Lin JY; Ohshima T; Shimotohno K
FEBS Lett; 2004 Aug; 573(1-3):15-8. PubMed ID: 15327968
[TBL] [Abstract][Full Text] [Related]
4. SUMO E3 ligase activity of TRIM proteins.
Chu Y; Yang X
Oncogene; 2011 Mar; 30(9):1108-16. PubMed ID: 20972456
[TBL] [Abstract][Full Text] [Related]
5. MEL-18 interacts with HSF2 and the SUMO E2 UBC9 to inhibit HSF2 sumoylation.
Zhang J; Goodson ML; Hong Y; Sarge KD
J Biol Chem; 2008 Mar; 283(12):7464-9. PubMed ID: 18211895
[TBL] [Abstract][Full Text] [Related]
6. Alternative splicing factor or splicing factor-2 plays a key role in intron retention of the endoglin gene during endothelial senescence.
Blanco FJ; Bernabeu C
Aging Cell; 2011 Oct; 10(5):896-907. PubMed ID: 21668763
[TBL] [Abstract][Full Text] [Related]
7. A serine/arginine-rich domain in the human U1 70k protein is necessary and sufficient for ASF/SF2 binding.
Cao W; Garcia-Blanco MA
J Biol Chem; 1998 Aug; 273(32):20629-35. PubMed ID: 9685421
[TBL] [Abstract][Full Text] [Related]
8. Ubc9 fusion-directed SUMOylation (UFDS): a method to analyze function of protein SUMOylation.
Jakobs A; Koehnke J; Himstedt F; Funk M; Korn B; Gaestel M; Niedenthal R
Nat Methods; 2007 Mar; 4(3):245-50. PubMed ID: 17277783
[TBL] [Abstract][Full Text] [Related]
9. PML IV/ARF interaction enhances p53 SUMO-1 conjugation, activation, and senescence.
Ivanschitz L; Takahashi Y; Jollivet F; Ayrault O; Le Bras M; de Thé H
Proc Natl Acad Sci U S A; 2015 Nov; 112(46):14278-83. PubMed ID: 26578773
[TBL] [Abstract][Full Text] [Related]
10. Involvement of PIAS1 in the sumoylation of tumor suppressor p53.
Kahyo T; Nishida T; Yasuda H
Mol Cell; 2001 Sep; 8(3):713-8. PubMed ID: 11583632
[TBL] [Abstract][Full Text] [Related]
11. The splicing factor-associated protein, p32, regulates RNA splicing by inhibiting ASF/SF2 RNA binding and phosphorylation.
Petersen-Mahrt SK; Estmer C; Ohrmalm C; Matthews DA; Russell WC; Akusjärvi G
EMBO J; 1999 Feb; 18(4):1014-24. PubMed ID: 10022843
[TBL] [Abstract][Full Text] [Related]
12. The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.
Kumar R; González-Prieto R; Xiao Z; Verlaan-de Vries M; Vertegaal ACO
Nat Commun; 2017 Nov; 8(1):1809. PubMed ID: 29180619
[TBL] [Abstract][Full Text] [Related]
13. HnRNP A1/A2 and SF2/ASF regulate alternative splicing of interferon regulatory factor-3 and affect immunomodulatory functions in human non-small cell lung cancer cells.
Guo R; Li Y; Ning J; Sun D; Lin L; Liu X
PLoS One; 2013; 8(4):e62729. PubMed ID: 23658645
[TBL] [Abstract][Full Text] [Related]
14. Identification of nuclear and cytoplasmic mRNA targets for the shuttling protein SF2/ASF.
Sanford JR; Coutinho P; Hackett JA; Wang X; Ranahan W; Caceres JF
PLoS One; 2008 Oct; 3(10):e3369. PubMed ID: 18841201
[TBL] [Abstract][Full Text] [Related]
15. The second RNA-binding domain of the human splicing factor ASF/SF2 is the critical domain controlling adenovirus E1A alternative 5'-splice site selection.
Dauksaite V; Akusjärvi G
Biochem J; 2004 Jul; 381(Pt 2):343-50. PubMed ID: 15068396
[TBL] [Abstract][Full Text] [Related]
16. Regulation of SRp20 exon 4 splicing.
Jumaa H; Nielsen PJ
Biochim Biophys Acta; 2000 Nov; 1494(1-2):137-43. PubMed ID: 11072076
[TBL] [Abstract][Full Text] [Related]
17. The Mdm-2 amino terminus is required for Mdm2 binding and SUMO-1 conjugation by the E2 SUMO-1 conjugating enzyme Ubc9.
Buschmann T; Lerner D; Lee CG; Ronai Z
J Biol Chem; 2001 Nov; 276(44):40389-95. PubMed ID: 11384992
[TBL] [Abstract][Full Text] [Related]
18. E2-mediated small ubiquitin-like modifier (SUMO) modification of thymine DNA glycosylase is efficient but not selective for the enzyme-product complex.
Coey CT; Fitzgerald ME; Maiti A; Reiter KH; Guzzo CM; Matunis MJ; Drohat AC
J Biol Chem; 2014 May; 289(22):15810-9. PubMed ID: 24753249
[TBL] [Abstract][Full Text] [Related]
19. HIV Rev-dependent binding of SF2/ASF to the Rev response element: possible role in Rev-mediated inhibition of HIV RNA splicing.
Powell DM; Amaral MC; Wu JY; Maniatis T; Greene WC
Proc Natl Acad Sci U S A; 1997 Feb; 94(3):973-8. PubMed ID: 9023367
[TBL] [Abstract][Full Text] [Related]
20. Chromatin binding of SRp20 and ASF/SF2 and dissociation from mitotic chromosomes is modulated by histone H3 serine 10 phosphorylation.
Loomis RJ; Naoe Y; Parker JB; Savic V; Bozovsky MR; Macfarlan T; Manley JL; Chakravarti D
Mol Cell; 2009 Feb; 33(4):450-61. PubMed ID: 19250906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
